Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Microsatellite Unstable Colorectal Cancer × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Melanoma 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Various Advanced Cancer 1 Uveal Melanoma 1 Urothelial Cancer 1 Stomach Neoplasms 1 Microsatellite Unstable Colorectal Cancer 1 Mesothelioma 1 Colorectal Neoplasms 1 Advanced or Metastatic Solid Tumors 1 Adenocarcinoma Of Esophagus 1

Interventions

relatlimab 1 daratumumab 1 cobimetinib 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02060188 2025-11-06

CheckMate142

Bristol-Myers Squibb

Phase 2 Completed

385 enrolled 17 charts 2 FDA

GastrointestinalOther solid neoplasm

Microsatellite Unstable Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡